Cytology Triage for HPV ‐Positive Postmenopausal Women in a Setting of Cervical Cancer Screening
Diagnostic Cytopathology · 2025
DOI: 10.1002/dc.25456 ↗At a glance
Journal article in Diagnostic Cytopathology, 2025. Written by Aparna Chacko and 3 co-authors. Institution: Department of Pathology, St. John's Medical College, Bangalore, India. Major MEDLINE topics: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia. Cited 1 times so far (Crossref); 16 references.
Abstract (original language)
Background
Globally, cervical cytology continues to serve as the cornerstone of cervical cancer screening programs, but WHO 2021 guidelines advocate HPV DNA testing as the primary screening modality due to its heightened sensitivity. This method necessitates additional triage with cytology or colposcopy to detect precancerous lesions. Hormonal shifts and anatomical alterations in postmenopausal women may impact diagnostic outcomes in either modality.
Aim
To describe the spectrum of cytological lesions in HPV‐positive postmenopausal women to detect precancerous lesions as part of cervical cancer screening.
Methods
Conventional cytology smears of high‐risk HPV‐positive postmenopausal women were reported according to The Bethesda System 2014. Results of follow‐up biopsies of the positive smears were recorded, and cyto‐histological correlation was performed.
Results
The retrospective study included conventional cytology smears of 124 postmenopausal women positive for high‐risk HPV DNA with a mean age of 52 years. Of the 124 cases, 68 were positive for HPV 16 and/or 18, and 56 were positive for other high‐risk HPV. On cytology, 78% were negative for intraepithelial lesions. HSIL+ lesions were noted in 12%, and low‐grade lesions were noted in 10% of smears with HPV16/18 predominance. Follow‐up biopsies of 17 smears revealed SCC in two cases, HSIL+ in 11 cases, LSIL in 2, and 2 were negative/benign lesions. Of the cyto‐histological discordant cases, four were upgraded on review.
Conclusion
Cytology is a useful triage tool in detecting preinvasive and early invasive tumors in HPV DNA‐positive postmenopausal women.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology, St. John's Medical College, Bangalore, India.
- Department of Gynaecological Oncology, St. John's Medical College Hospital, Bangalore, India.
ORCID profiles: Julian Crasta
Cite
APA
Chacko, A., Bidkar, V. C., Acharya, G., & Crasta, J. (2025). Cytology Triage for HPV ‐Positive Postmenopausal Women in a Setting of Cervical Cancer Screening. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25456
Vancouver
Chacko A, Bidkar VC, Acharya G, Crasta J. Cytology Triage for HPV ‐Positive Postmenopausal Women in a Setting of Cervical Cancer Screening. Diagnostic Cytopathology. 2025. doi:10.1002/dc.25456
BibTeX
@article{Chacko2025,
author = {Chacko, Aparna and Bidkar, Vishaka C and Acharya, Geeta and Crasta, Julian},
title = {Cytology Triage for HPV ‐Positive Postmenopausal Women in a Setting of Cervical Cancer Screening},
journal = {Diagnostic Cytopathology},
year = {2025},
doi = {10.1002/dc.25456}
}
EUVIMED